Merck Expands Cancer Research Beyond Keytruda
Merck & Co. has long been known for its cancer drug Keytruda. But with Keytruda’s patents set to expire soon, […]
How Nonprofits Are Changing the Game in Rare Disease Treatments
Nonprofit organizations are playing a big role in developing treatments for rare diseases, especially when big companies aren’t interested. Gene
AI’s Impact on Jobs: A Pharmacist’s Perspective on the Biopharma Industry
Super Bowl ads often set cultural trends, and this year, AI was a hot topic with about 23% of commercials
Novo Nordisk Teams Up to Create Easy-to-Take Obesity and Metabolic Disease Drugs
Novo Nordisk, a big name in pharmaceuticals, has teamed up with a smaller company called Vivtex. This partnership aims to
Pharmaceutical News
Pharmaceutical Updates: Simplified
Here are the latest updates from the pharmaceutical industry, explained in simple terms: 1. **Charles River Laboratories**: This company is
New HIV Treatment Shows Promise in Maintaining Viral Suppression
Gilead has shared new results from its ARTISTRY-1 and ARTISTRY-2 trials, which looked at how well a new combination of
Axol Bioscience Expands Eye Research with Newcells Biotech Deal
Axol Bioscience has bought the eye research part of Newcells Biotech. This deal helps Axol offer more types of lab-grown
New Treatment Option for Severe Asthma and Nasal Polyps Approved in Europe
A new medicine called Exdensur (depemokimab) has been approved in Europe for two conditions: severe asthma with type 2 inflammation
Pharmaceutical News
Pharmacist’s Perspective: Latest Updates in the Pharmaceutical World
As a pharmacist, I’d like to share some recent news in the pharmaceutical industry and explain it in simple terms.
Atlanta Company Raises $75 Million to Develop Lung Disease Treatment
An Atlanta-based biotechnology company called Altesa BioSciences recently announced that it has raised $75 million to further develop a drug